FGF9 and central nervous system cancer: FGF9 is first identified from the secretions of human glioma MCF-G1 cells, and could promote NIH-3T3 cell line malignant transformation, suggesting that FGF9 may be a tumor-promoting factor (Naruo et al., 1993).